Amunix is an industry leader in the discovery and development of long-acting protein- and peptide therapeutics. Founded in 2006, amunix is backed by investors that include Polaris Partners, Venrock, Frazier Healthcare Partners, Redmile Group, and Casdin Capital and is headquartered in Mountain View.